Sirt1 is a tumor promoter in lung adenocarcinoma

Oncology Letters

Volumn 8, Issue 1, 2014, Pages 387-393

  Chen, Xue ^a   Hokka, Daisuke ^a   Maniwa, Yoshimasa ^a   Ohbayashi, Chiho ^b   Itoh, Tomoo ^a   Hayashi, Yoshitake ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cellular senescence; Hypoxia inducible factor 1; Lung adenocarcinoma; Sirtuin 1

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; PROTEIN P53; SIRTUIN 1; TRANSCRIPTION FACTOR FKHRL1;

ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR INVASION;

EID: 84901241107     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2057     Document Type: Article

References (31)

1. Jeyapalan JC and Sedivy JM: Cellular senescence and organismal aging. Mech Ageing Dev 129: 467-474, 2008.
2. Krtolica A and Campisi J: Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol 34: 1401-1414, 2002.
3. Lombard DB, Chua KF, Mostoslavsky R, et al: DNA repair, genome stability, and aging. Cell 120: 497-512, 2005.
4. Jung-Hynes B and Ahmad N: Role of p53 in the anti-proliferative effects of Sirt1 inhibition in prostate cancer cells. Cell Cycle 8: 1478-1483, 2009.
5. Yi J and Luo J: SIRT1 and p53, effect on cancer, senescence and beyond. Biochim Biophys Acta 1804: 1684-1689, 2010.
6. Liu T, Liu PY and Marshall GM: The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Res 69: 1702-1705, 2009.
7. Fang Y and Nicholl MB: Sirtuin 1 in malignant transformation: friend or foe? Cancer Lett 306: 10-14, 2011.
8. Tseng RC, Lee CC, Hsu HS, et al: Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients. Neoplasia 11: 763-770, 2009.
9. Deng CX: SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci 5: 147-152, 2009.
10. Kim JE, Chen J and Lou Z: DBC1 is a negative regulator of SIRT1. Nature 451: 583-586, 2008.
11. Abdelmohsen K, Pullmann R Jr, Lal A, et al: Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell 25: 543-557, 2007.
12. Kim EJ, Kho JH, Kang MR and Um SJ: Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol Cell 28: 277-290, 2007.
13. Ford J, Jiang M and Milner J: Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Cancer Res 65, 10457-10463, 2005.
14. Huffman DM, Grizzle WE, Bamman MM, et al: SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res 67: 6612-6618, 2007.
15. Bradbury C, Khanim FL, Hayden R, et al: Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia 19: 1751-1759, 2005.
16. Kabra N, Li Z, Chen L, et al: SirT1 is an inhibitor of proliferation and tumor formation in colon cancer. J Biol Chem 284: 18210-18217, 2009.
17. Yeung F, Hoberg JE, Ramsey CS, et al: Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23: 2369-2380, 2004
18. Tang, Y, Zhao W, Chen Y, Zhao Y and Gu W: Acetylation is indispensable for p53 activation. Cell 133: 612-626, 2008.
19. Wang C, Chen L, Hou X, et al: Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol 8: 1025-1031, 2006.
20. Stünkel W, Peh BK, Tan YC, et al: Function of the SIRT1 protein deacetylase in cancer. Biotechnol J 2: 1360-1368, 2007.
21. Brunet A, Sweeney LB, Sturgill JF, et al: Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-2015, 2004.
22. Kobayashi Y, Furukawa-Hibi Y, Chen C, et al: SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. Int J Mol Med 16: 237-243, 2005.
23. An BS, Tavera-Mendoza LE, Dimitrov V, et al: Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor. Mol Cell Biol 30: 4890-4900, 2010.
24. Hokka D, Maniwa Y, Tane S, et al: Psf3 is a prognostic biomarker in lung adenocarcinoma. Lung Cancer 79: 77-82, 2013.
25. Satoh N, Maniwa Y, Bermudez VP, Nishimura K, Nishio W, Yoshimura M, et al: Oncogenic hosphatase Wip1 is a novel prognostic marker for lung adenocarcinoma patient survival. Cancer Sci 102: 1101-1106, 2011.
26. Nakai R, Maniwa Y, Tanaka Y, Nishio W, Yoshimura M, Okita Y, et al: Overexpression of Necl-5 correlates with unfavorable prognosis in patients with lung adenocarcinoma. Cancer Sci 101: 1326-1330, 2010.
27. Ke Q and Costa M: Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70: 1469-1480, 2006
28. Volm M and Koomägi R: Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res 20: 1527-1533, 2000.
29. Greijer AE and van der Wall E: The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 57: 1009-1014, 2004.
30. Halliwell B: Oxidative stress and cancer: have we moved forward? Biochem J 401: 1-11, 2007.
31. Brooks CL and Gu W: How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer 9: 123-128, 2009.